Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 Results

被引：2
|
作者：
Porcu, Pierluigi
Haverkos, Bradley
Alpdogan, Onder
Baiocchi, Robert
Brammer, Jonathan E.
Feldman, Tatyana A.
Capra, Marcelo
Brem, Elizabeth A.
Scheinberg, Phillip
Pereira, Juliana
Shune, Leyla
Katkov, Afton
Mcrae, Robert
Rojkjaer, Lisa
Royston, Ivor
Faller, Douglas V.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140843
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] A phase Ib/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas.
    Porcu, Pierluigi
    Haverkos, Bradley
    Brem, Elizabeth
    Vallurupalli, Anusha
    Feldman, Tatyana
    Alpdogan, Onder
    Brammer, Jonathan Edward
    Bryan, Locke Johnson
    Barta, Stefan K.
    Obrzut, Sebastian
    Shen, Hao
    Rochford, Rosemary
    Baiocchi, Robert A.
    Casper, Corey
    Gutheil, John
    McRae, Robert
    Daniels, Preston
    Warren, Marshelle Smith
    Royston, Ivor
    Faller, Douglas V.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] (Nstat) and Valganciclovir (VGCV) in Relapsed/Refractory (R/R) Epstein-Barr Virus-Positive (EBV plus ) Lymphomas: Final Results from the Phase 1b/2 VT3996-201 Study
    Haverkos, Bradley M.
    Alpdogan, Onder
    Baiocchi, Robert
    Brammer, Jonathan E.
    Feldman, Tatyana A.
    Capra, Marcelo
    Brem, Elizabeth A.
    Nair, Santosh M.
    Scheinberg, Phillip
    Pereira, Juliana
    Shune, Leyla
    Joffe, Erel
    Katkov, Afton
    McRae, Robert
    Royston, Ivor
    Rojkjaer, Lisa
    Porcu, Pierluigi
    BLOOD, 2021, 138
  • [3] A phase 1b/2 study of nanatinostat and valganciclovir in patients with advanced Epstein-Barr virus positive (EBV+) solid tumors and in combination with pembrolizumab in patients with recurrent/metastatic nasopharyngeal carcinoma (RM-NPC).
    Colevas, A. Dimitrios
    Siu, Lillian L.
    Lim, Darren Wan-Teck
    Gao, Bo
    Rojkjaer, Lisa
    Katkov, Afton
    Katz, Yisrael
    Ma, Brigette
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study
    Porcu, Pierluigi
    Haverkos, Brad M.
    Alpdogan, Onder
    Capra, Marcelo
    Feldman, Tatyana A.
    Brem, Elizabeth
    Vallurupalli, Anusha
    Brammer, Jonathan E.
    Schriefer, Ana
    Pereira, Juliana
    Tulpule, Anil
    Barta, Stefan K.
    Bryan, Locke J.
    Trauger, Richard
    Obrzut, Sebastian
    Gutheil, John
    Katkov, Afton
    McRae, Robert
    Royston, Ivor
    Faller, Douglas V.
    BLOOD, 2019, 134
  • [5] A phase Ib/II study of nanatinostat (Nstat) plus valganciclovir (VGCV) in EBV plus solid tumors and with pembrolizumab (PEM) in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC)
    Colevas, A. D.
    Siu, L.
    Lim, D. W-T.
    Gao, B.
    Voon, P-J.
    Khan, S.
    Eng, L.
    Ahn, M-J.
    Lee, V.
    Wang, H. M.
    Yang, M-H.
    Bowles, D.
    Ferrarotto, R.
    Elguindy, A.
    Katkov, A.
    McGovern, K.
    Ma, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1607 - S1607
  • [6] Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas
    Yilmaz, Elif
    Lakhotia, Rahul
    Pittaluga, Stefania
    Muppidi, Jagan R.
    Phelan, James D.
    Evans, Sarah
    Pradhan, Amynah
    Hillsman, Amy
    Steinberg, Seth M.
    Jaffe, Elaine S.
    Wilson, Wyndham H.
    Roschewski, Mark
    Melani, Christopher
    BLOOD, 2021, 138
  • [7] Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPD) and EBV-Positive Non-Hodgkin Lymphomas (NHL)
    Dalela, Disha
    Lakhotia, Rahul
    Pittaluga, Stefania
    Muppidi, Jagan
    Steinberg, Seth
    Phelan, James
    Evans, Sarah
    Pradhan, Amynah
    Jaffe, Elaine
    Wilson, Wyndham
    Roschewski, Mark
    Melani, Christopher
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S451 - S451
  • [8] Detection of Epstein-Barr virus (EBV) in the oral mucosa of renal transplant patients
    Braz-Silva, PH
    Ortega, KL
    Rezende, NP
    Nunes, FD
    Magalhaes, MHCG
    DIAGNOSTIC CYTOPATHOLOGY, 2006, 34 (01) : 24 - 28
  • [9] A Global Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With EBV-Positive (EBV plus ) Relapsed/Refractory Peripheral T Cell Lymphomas (NAVAL-
    Nair, Ranjit
    Chang, Hung
    Greenwell, Irl Brian
    Hsiao, Hui-Hua
    Ayer, Swaminathan
    Zinzani, Luigi
    Strickland, Donald
    Gonzalez-Barca, Eva
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S527 - S527
  • [10] INTERFERON (IFN) PRODUCTION BY PATIENTS WITH CHRONIC RECURRENT EPSTEIN-BARR VIRUS (EBV) INFECTIONS
    JONES, JF
    LUCAS, DO
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 969 - 969
12345